Clinical Trial Update: A Study to Assess the Efficacy and Safety of Oral CL-H1T in the Treatment of Acute Migraine Pain [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating the efficacy and safety of oral CL-H1T for acute migraine pain has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• CL-H1T

Snippet

Sponsor: Charleston Laboratories, Inc | Conditions: Migraine, Pain | Phase 2 | Status: COMPLETED